By Joseph Stiglitz – Unlike the United States, which could spend one-quarter of its GDP protecting its economy from the COVID-19 fallout, Argentina entered the pandemic with the deck stacked against it. Yet, thanks to the current government’s policies to strengthen the real economy, the country has been enjoying a remarkable recovery.
Norwegian Cruise Line which this week was expected to begin trips along with the Argentine and Chilean coasts, as well as Antarctica cruises, has surprisingly announced it was cancelling its South American operations this season because of covid-19 related circumstances which have forced the company to reschedule its global plans.
Effective Jan. 12, the Government of Paraguay will require at least two doses of a COVID-19 vaccine to anyone who wishes to enter the country, it was announced, except for people who have been treated with single-dose drugs.
Multiple cases of COVID-19 are leaving companies understaffed but when it comes down to airline services it becomes far more notorious because scores of angry passengers fill airports everywhere.
An Australian Circuit Court Monday ruled in favor of reinstating tennis' top player Novak Djokovic his visa, which was canceled by immigration officials on the grounds that he was not vaccinated against COVID-19.
With 18% of its crews on sick leave due to COVID-19, Latam Airlines Colombia has been forced to cancel some 53 domestic flights between Jan. 8 and 16. Most of the cases were said to be of the Omicron variant.
Cypriot health researchers have warned about the existence of yet a new variant of SARS-CoV-2, known as Deltacron, a combination of the relatively new Delta and Omicron strains. According to the scientists, the new variant has the omicron genetic signature and the delta genomes.
Chile's Medical College said that the coronavirus situation in Argentina was critical as a result of the Omicron variant and advised against traveling to the neighboring country.
Brazil's National Health Surveillance Agency (Anvisa) Friday approved the first nationally manufactured COVID-19 vaccine. The body is also considering a second pediatric drug after having cleared Pfizer's for children aged 5 to 11.
Peruvian Health authorities have reported the detection of three infections and also one death of flurona, the new portmanteau disease resulting from the overlapping of COVID-19 with influenza.